PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures

NAUnknownINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Prostate Cancer
Interventions
PROCEDURE

Standard of Care

Men in Arm B will undergo a 12-core systematic TRUS guided biopsy. All men in the study will be followed for two years or until they have had radical treatment (whichever comes first).

PROCEDURE

MRI

Men will undergo a MRI followed by either a targeted biopsy of suspicious areas or will be followed for two years if there is no suspicious areas identified by MRI.

PROCEDURE

MRI Targeted Biopsy

Men will undergo a MRI followed by either a targeted biopsy of suspicious areas or will be followed for two years if there is no suspicious areas identified by MRI.

Trial Locations (5)

V5Z1M9

NOT_YET_RECRUITING

Vancouver Prostate Centre, Vancouver

N6A5W9

RECRUITING

London Health Sciences Centre-Victoria Hospital, London

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

M5G1X6

RECRUITING

Princess Margaret Cancer Centre, Toronto

H3T1E2

RECRUITING

CIUSSS du Centre-Ouest-de-I'ile-de-Montreal-Jewish General Hospital, Montreal

Sponsors
All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

collaborator

Prostate Cancer Canada

OTHER

lead

Canadian Urology Research Consortium

OTHER